Endonovo Therapeutics ENDV Stock
Endonovo Therapeutics Price Chart
Endonovo Therapeutics ENDV Financial and Trading Overview
| Endonovo Therapeutics stock price | 0.0001 USD |
| Previous Close | 0 USD |
| Open | 0.0002 USD |
| Bid | 0.0002 USD x 0 |
| Ask | 0.0002 USD x 0 |
| Day's Range | 0.0002 - 0.0002 USD |
| 52 Week Range | 0.0001 - 0.002 USD |
| Volume | 220K USD |
| Avg. Volume | 21.91M USD |
| Market Cap | 109.79K USD |
| Beta (5Y Monthly) | -2.039 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ENDV Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.42933956 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Endonovo Therapeutics Stock Price History
| Beta (5Y Monthly) | -2.039 |
| 52-Week Change | -95.00000000000000000000000000000000% |
| S&P500 52-Week Change | 8.39% |
| 52 Week High | 0.002 USD |
| 52 Week Low | 0.0001 USD |
| 50-Day Moving Average | 0.000188 USD |
| 200-Day Moving Average | 0.000655 USD |
ENDV Share Statistics
| Avg. Volume (3 month) | 21.91M USD |
| Avg. Daily Volume (10-Days) | 1.02M USD |
| Shares Outstanding | 1.1B |
| Float | 255.51M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | NaN |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | September 30, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -31105.065% |
| Gross Margin | 96.21% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -144.26% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 255.72K USD |
| Revenue Per Share (ttm) | 0.001 USD |
| Quarterly Revenue Growth (yoy) | -86.099% |
| Gross Profit (ttm) | 246.03K USD |
| EBITDA | -1969534 USD |
| Net Income Avi to Common (ttm) | -4404143 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | 7.06M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.001 |
| Book Value Per Share (mrq) | -0.072 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -629904 USD |
| Levered Free Cash Flow (ttm) | 2.15M USD |
Profile of Endonovo Therapeutics
| Country | United States |
| State | CA |
| City | Woodland Hills |
| Address | 6320 Canoga Avenue |
| ZIP | 91367 |
| Phone | 800 489 4774 |
| Website | https://www.endonovo.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of cardiovascular diseases, chronic kidney, liver diseases, non-alcoholic steatohepatitis, cardiovascular and peripheral artery diseases, and ischemic stroke, as well as for central nervous system disorders, such as traumatic brain injury, acute concussions, post-concussion syndrome, stroke, and multiple sclerosis. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.
Q&A For Endonovo Therapeutics Stock
What is a current ENDV stock price?
Endonovo Therapeutics ENDV stock price today per share is 0.0001 USD.
How to purchase Endonovo Therapeutics stock?
You can buy ENDV shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Endonovo Therapeutics?
The stock symbol or ticker of Endonovo Therapeutics is ENDV.
Which industry does the Endonovo Therapeutics company belong to?
The Endonovo Therapeutics industry is Biotechnology.
How many shares does Endonovo Therapeutics have in circulation?
The max supply of Endonovo Therapeutics shares is 1.1B.
What is Endonovo Therapeutics Price to Earnings Ratio (PE Ratio)?
Endonovo Therapeutics PE Ratio is now.
What was Endonovo Therapeutics earnings per share over the trailing 12 months (TTM)?
Endonovo Therapeutics EPS is 0 USD over the trailing 12 months.
Which sector does the Endonovo Therapeutics company belong to?
The Endonovo Therapeutics sector is Healthcare.